Research location
Iesi
Italy
Advertisement
Research activity in Iesi
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Iesi
8 linked trials · page 1 of 1A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MethotrexateNCT01636843 · 2012-10-30 · 1 site observation
TERMINATED
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsNCT01636817 · 2012-08-01 · 1 site observation
TERMINATED
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid ArthritisNCT01443364 · 2011-12-01 · 1 site observation
COMPLETED
Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) InhibitorsNCT00960440 · 2009-10-01 · 1 site observation
COMPLETED
The Clinical Evaluation of the Dose of Erythropoietins TrialNCT00827021 · 2009-07-01 · 1 site observation
COMPLETED
Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisNCT00717236 · 2008-07-01 · 1 site observation
COMPLETED
Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation
COMPLETED
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid ArthritisNCT00042068 · 2002-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.